Using antibiotics in suspected haemolytic-uraemic syndrome
EDITOR-By uncritically quoting the meta-analysis of Safdar et al in their evidence based case report, Phillips et al perpetuate an error about antibiotic treatment of Escherichia coli O157:H7 infections. 1 2 Specifically, Safdar et al mischaracterised a study by Ikeda et al as showing that treatment...
Gespeichert in:
Veröffentlicht in: | BMJ 2005-05, Vol.330 (7501), p.1209-1209 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | EDITOR-By uncritically quoting the meta-analysis of Safdar et al in their evidence based case report, Phillips et al perpetuate an error about antibiotic treatment of Escherichia coli O157:H7 infections. 1 2 Specifically, Safdar et al mischaracterised a study by Ikeda et al as showing that treatment of E coli O157:H7 infections with fosfomycin diminished the risk of haemolytic-uraemic syndrome compared with no antibiotic treatment. 3 However, Ikeda et al did not show that antibiotics prevent the syndrome because two of the 256 patients were not treated. [...]statistically significant benefit emerged only after subgroup analysis, with the implication that treatment had value only if started on day 2 of illness. |
---|---|
ISSN: | 0959-8138 1468-5833 1756-1833 |
DOI: | 10.1136/bmj.330.7501.1209 |